172@29@16@52!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Oct 22, 16:00
782.45 -22.85 (-2.84%)
Volume
AVERAGE VOLUME
5-Day
68,612
10-Day
92,633
30-Day
150,275
346,002
  • Prev. Close

    805.30

  • Open Price

    809.80

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 22, 15:59
782.20 -24.00 (-2.98%)
Volume
AVERAGE VOLUME
5-Day
2,323,476
10-Day
2,690,163
30-Day
3,859,677
12,465,607
  • Prev. Close

    806.20

  • Open Price

    807.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    782.20 (6709)

Financials

2019 2018 2017 2016 2015
Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
Per Share Ratios  
Basic EPS (Rs.) 31.96 26.11 30.94 29.16 27.85  
Diluted EPS (Rs.) 31.96 26.11 30.94 29.16 27.85  
Cash EPS (Rs.) 39.99 33.16 37.00 34.01 32.29  
Book Value [ExclRevalReserve]/Share (Rs.) 222.32 193.73 170.38 143.99 117.32  
Book Value [InclRevalReserve]/Share (Rs.) 222.32 193.73 170.38 143.99 117.32  
Dividend / Share(Rs.) 3.00 2.50 2.50 2.50 2.50  
Revenue from Operations/Share (Rs.) 226.43 209.21 175.28 163.97 156.63  
PBDIT/Share (Rs.) 52.72 44.52 46.95 42.84 45.12  
PBIT/Share (Rs.) 44.69 37.47 40.89 37.95 40.62  
PBT/Share (Rs.) 40.58 33.53 39.99 37.18 36.70  
Net Profit/Share (Rs.) 31.96 26.11 30.94 29.13 27.80  
Profitability Ratios  
PBDIT Margin (%) 23.28 21.28 26.78 26.12 28.80  
PBIT Margin (%) 19.73 17.91 23.32 23.14 25.93  
PBT Margin (%) 17.92 16.02 22.81 22.67 23.43  
Net Profit Margin (%) 14.11 12.47 17.65 17.76 17.74  
Return on Networth / Equity (%) 14.37 13.47 18.15 20.23 23.69  
Return on Capital Employed (%) 19.87 19.25 23.86 25.92 22.52  
Return on Assets (%) 9.58 8.43 11.47 13.10 12.94  
Total Debt/Equity (X) 0.29 0.40 0.37 0.34 0.55  
Asset Turnover Ratio (%) 67.91 67.57 65.02 73.77 72.94  
Liquidity Ratios  
Current Ratio (X) 1.77 1.55 1.56 1.55 1.45  
Quick Ratio (X) 1.09 0.96 0.97 1.01 1.00  
Inventory Turnover Ratio (X) 3.07 3.09 3.01 3.95 3.77  
Dividend Payout Ratio (NP) (%) 9.38 9.57 12.12 6.68 8.26  
Dividend Payout Ratio (CP) (%) 7.50 7.53 10.13 5.72 7.11  
Earnings Retention Ratio (%) 90.62 90.43 87.88 93.32 91.74  
Cash Earnings Retention Ratio (%) 92.50 92.47 89.87 94.28 92.89  
Valuation Ratios  
Enterprise Value (Cr.) 27,852.67 50,495.77 36,057.21 42,393.57 47,018.50  
EV/Net Operating Revenue (X) 2.10 4.12 3.51 4.41 5.13  
EV/EBITDA (X) 9.02 19.36 13.11 16.89 17.81  
MarketCap/Net Operating Revenue (X) 1.82 3.76 3.18 4.12 4.76  
Retention Ratios (%) 90.61 90.42 87.87 93.31 91.73  
Price/BV (X) 1.86 4.06 3.27 4.69 6.35  
Price/Net Operating Revenue 1.82 3.76 3.18 4.12 4.76  
Earnings Yield 0.08 0.03 0.06 0.04 0.04  
Source : Dion Global Solutions Limited